Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Flowers

Showing results (131-140 of 247) with videos related to

Pageof 25
Sort By:
Blood|May 13, 2017
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host diseasePaul J Martin, Barry E Storer, Yoshihiro Inamoto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 30, 2020
Who Enrolls in an Online Cancer Survivorship Program? Reach of the INSPIRE Randomized Controlled Trial for Hematopoietic Cell Transplantation SurvivorsJean C Yi, Brie Sullivan, Wendy M Leisenring, et al.
Transplantation|March 30, 2006
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantationLauri Burroughs, Marco Mielcarek, Wendy Leisenring, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 26, 2014
Late cardiovascular complications after hematopoietic cell transplantationEric J Chow, Kenneth Wong, Stephanie J Lee, et al.
British Journal of Haematology|April 27, 2012
Success of allogeneic marrow transplantation for children with severe aplastic anaemiaLauri M Burroughs, Ann E Woolfrey, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2009
Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantationStephanie J Lee, Travis Seaborn, Frances J Mao, et al.
Plant Disease|February 7, 2019
Spring Wheat Tolerance and Resistance to Heterodera avenae in the Pacific NorthwestRichard W Smiley, Juliet M Marshall, Jennifer A Gourlie, et al.
Blood Advances|April 1, 2020
Late infectious complications in hematopoietic cell transplantation survivors: a population-based studyAimee M Foord, Kara L Cushing-Haugen, Michael J Boeckh, et al.
Blood|July 1, 2020
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donorsBrian Kornblit, Barry E Storer, Niels S Andersen, et al.
Blood Advances|June 4, 2020
Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantationYoshihiro Inamoto, Paul J Martin, Stephanie J Lee, et al.
Pageof 25

Showing results (131-140 of 247) with videos related to

Sort By:
Pageof 25
Blood|May 13, 2017
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host diseasePaul J Martin, Barry E Storer, Yoshihiro Inamoto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 30, 2020
Who Enrolls in an Online Cancer Survivorship Program? Reach of the INSPIRE Randomized Controlled Trial for Hematopoietic Cell Transplantation SurvivorsJean C Yi, Brie Sullivan, Wendy M Leisenring, et al.
Transplantation|March 30, 2006
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantationLauri Burroughs, Marco Mielcarek, Wendy Leisenring, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 26, 2014
Late cardiovascular complications after hematopoietic cell transplantationEric J Chow, Kenneth Wong, Stephanie J Lee, et al.
British Journal of Haematology|April 27, 2012
Success of allogeneic marrow transplantation for children with severe aplastic anaemiaLauri M Burroughs, Ann E Woolfrey, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2009
Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantationStephanie J Lee, Travis Seaborn, Frances J Mao, et al.
Plant Disease|February 7, 2019
Spring Wheat Tolerance and Resistance to Heterodera avenae in the Pacific NorthwestRichard W Smiley, Juliet M Marshall, Jennifer A Gourlie, et al.
Blood Advances|April 1, 2020
Late infectious complications in hematopoietic cell transplantation survivors: a population-based studyAimee M Foord, Kara L Cushing-Haugen, Michael J Boeckh, et al.
Blood|July 1, 2020
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donorsBrian Kornblit, Barry E Storer, Niels S Andersen, et al.
Blood Advances|June 4, 2020
Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantationYoshihiro Inamoto, Paul J Martin, Stephanie J Lee, et al.
Pageof 25